The first SHIGETECVAX Annual Meeting took place on 20-21 October 2020.
About 30 participants from Austria (Eveliqure Biotechnologies), Bangladesh (icddr,b), Germany (European Vaccine Initiative), Sweden (University of Gothenburg) and USA (PATH), gathered together in a virtual meeting to discuss project achievements and future directions. The consortium was pleased to receive support and advice from the SHIGETECVAX Scientific and Ethics Advisory Committee.
Comments